GSTM1 and Familial prostate cancer: Our most interesting metabolic finding suggests an increase in the intensities of m-Ino in the Hb tissue of high aggressive diseases, as compared with Hb tissue from low aggressive prostate cancer and cancerous prostate tissue samples.